Advanced Prostate Cancer

Carboplatin-Taxane Combinations in the Management of Castration-resistant Prostate Cancer

The use of Docetaxel (chemotherapy) extends survival time in men with castration-resistant prostate cancer (CRPC). Many researchers believe that platinum compounds, particularly Carboplatin, when added to docetaxel (taxane-based chemotherapy) can further extend survival times. A study at the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Investigated the efficacy [...]

By Malecare|2020-02-04T11:38:11-05:00September 3rd, 2009|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Drugs & Treatments, Uncategorized|0 Comments

Stromal Biomarker Appears to Predict Advanced Prostate Cancer

The absence of a stromal protein called caveolin-1 appears to be a marker for advanced prostate cancer and for metastasis, researchers from the Kimmel Cancer Center at Jefferson and Harvard Medical School reported in "Cell Cycle." Caveolin-1 has already been shown to be a good biomarker serving as a prognostic factor for breast cancer. The [...]

By Malecare|2017-10-19T10:54:35-04:00September 2nd, 2009|Advanced Prostate Cancer, Research, Technology, Uncategorized, Understanding APC|0 Comments

President Obama Declares September as National Prostate Cancer Awareness Month

THE WHITE HOUSE Office of the Press Secretary ____________________________________________________________________________ For Immediate Release August 31, 2009 NATIONAL PROSTATE CANCER AWARENESS MONTH, SEPTEMBER 2009 - - - - - - - BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION As a Nation, we have made significant progress in the fight against prostate cancer. Over [...]

By Malecare|2017-10-19T10:54:36-04:00September 1st, 2009|Advanced Prostate Cancer, Politics of Cancer, Uncategorized|0 Comments

On the Horizon – Sunitinib Malate for Metastatic Castration-Resistant Prostate Cancer Following Docetaxel Chemotherapy

Docetaxel (Taxotere), or chemotherapy, will as all other treatments for advanced prostate cancer stop working. Many of us will progress quickly to this stage and eventually face a situation where there are no longer any approved treatments available to control our prostate cancer. If you are lucky enough to have an oncologist who is creative [...]

By Malecare|2017-10-19T10:54:37-04:00August 31st, 2009|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Clinical Trials, Drugs & Treatments, End-Of-Life, On The Horizon, Uncategorized, Understanding APC|0 Comments

Survival Benefit of Radical Prostatectomy In Lymph Node Positive Men with Prostate Cancer

In many places it is a common practice to stop a radical prostatectomy (prostate gland removal) if the surgeon finds that the patient has positive lymph nodes. Since positive nodes are considered systemic disease as opposed to a localized disease, many physicians have felt there is no reason to complete the surgery and subject the [...]

By Malecare|2009-08-30T08:46:57-04:00August 30th, 2009|Advanced Prostate Cancer, Drugs & Treatments, General Information, Uncategorized, Understanding APC|0 Comments